The FDA approval is based on safety and efficacy demonstrated in the phase 3 ARANOTE trial, which evaluated darolutamide — ...

Avant Technologies, Inc. ("Avant" or the "Company"), and its JV partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using ...

Workplace stress, on the rise for decades, has been treated by many organizations as a personal issue instead of a ...

The two reigning MVPs are the favorites to repeat, but there are several viable contenders who could make up ground in the coming months.

Most of the charts you see below are courtesy of Kyle Bland over at Pitcher List. He created a great spring training app ...

Sickness absence rates 2024: the rate dropped almost to pre-pandemic level, with the average days lost per worker at 4.4.

Global Akeega sales will reach $676 million by 2030, while Talzenna and saruparib reach $618 million and $628 million ...

The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, ...

BeOne Medicines' robust financial outlook is driven by zanubrutinib's rapid sales growth and anticipated positive cash flow.

Andersen looks at the top fantasy baseball prospects risers, sleepers for Week 10 of 2025. These MLB prospects may become ...

Optimizing partnerships with talent acquisition firms will help HR teams solidify their talent strategy for 2025.

The "repetitive" jobs like approving vacation requests, managing payroll or other company documentation will now be handled ...